Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

Boehm, Thomas, Folkman, Judah, Browder, Timothy, O'Reilly, Michael S.·1997·Nature
DOI 10.1038/37126

Cited by (1,002)

Items 501–600 of 1,002

  1. Is There a Role for Nitric Oxide in Tumor Angiogenesis?
    Guillermo García‐Cardeña, Judah Folkman · 1998 · JNCI Journal of the National Cancer Institute
  2. Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells
    Eddy Pasquier, Maria‐Pia Tuset, Janine A. Street, Snega M. Sinnappan, Karen L. MacKenzie, Diane Braguer, Nicolás André, Maria Kavallaris · 2012 · Angiogenesis
  3. Vaccination with autologous endothelium inhibits angiogenesis and metastasis of colon cancer through autoimmunity
    Yurai Okaji, Nelson Hirokazu Tsuno, Joji Kitayama, Shinsuke Saito, Tsuyoshi Takahashi, Kazushige Kawai, Kentaro Yazawa, Masahiro Asakage, Nobukazu Hori, Toshiaki Watanabe et al. · 2004 · Cancer Science
  4. Optimal and suboptimal protocols for a mathematical model for tumor anti-angiogenesis in combination with chemotherapy
    Urszula Ledzewicz, Helmut Maurer, Heinz Schättler · 2011 · Mathematical Biosciences & Engineering
  5. Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo
    Frank M. Klenke, Amir Abdollahi, Elisabeth Bertl, Martha Maria Gebhard, V. Ewerbeck, Peter Ernst Huber, Axel Sckell · 2007 · BMC Cancer
  6. Targeting Tumor Microenvironment with Silibinin: Promise and Potential for a Translational Cancer Chemopreventive Strategy
    Gagan Deep, Rajesh Agarwal · 2013 · Current Cancer Drug Targets
  7. VEGF Inhibitors and Prostate Cancer Therapy
    Jeanny B. Aragon‐Ching, William L. Dahut · 2009 · Current Molecular Pharmacology
  8. Targeted Therapy Against VEGFR and EGFR With ZD6474 Enhances the Therapeutic Efficacy of Irradiation in an Orthotopic Model of Human Non–Small-Cell Lung Cancer
    Keiko Shibuya, Ritsuko U Komaki, Tomoaki Shintani, Satoshi Itasaka, Anderson Joseph Ryan, Juliane Margarete Jürgensmeier, Luka Milas, Kian K Ang, Roy S. Herbst, Michael S. O’Reilly · 2007 · International Journal of Radiation Oncology*Biology*Physics
  9. Matrix Metalloproteinase Protocols
    Ian M. Clark · 2010 · Methods in molecular biology
  10. Antiangiogenic Therapy by Local Intracerebral Microinfusion Improves Treatment Efficiency and Survival in an Orthotopic Human Glioblastoma Model
    Nils Ole Schmidt, Mateo Ziu, Giorgio Giovanni Carrabba, Carlo Giorgio Giussani, Lorenzo Bello, Yanping Sun, Karl F. Schmidt, Mitchel Albert, Peter McL. Black, Rona Stephanie Carroll · 2004 · Clinical Cancer Research
  11. Mechanisms of metastasis
    Tri H. Nguyen · 2004 · Clinics in Dermatology
  12. Anti-angiogenic Treatment Strategies for Malignant Brain Tumors
    Matthias Kirsch, Gabriele Schackert, Peter McL. Black · 2000 · Journal of Neuro-Oncology
  13. Mechanistic insights on the inhibition of tumor angiogenesis
    Benilde Jiménez · 2001 · Journal of Molecular Medicine
  14. Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma
    Andréia Hanada Otake, Ana Lúcia Mattar, H. Freitas, Camila Maria Longo Machado, Suely Nonogaki, Clarice Kazue Fujihara, Roberto Zatz, Roger J. Chammas · 2009 · Cancer Chemotherapy and Pharmacology
  15. Anti-angiogenic Activity of a Novel Class of Chemopreventive Compounds: Oleanic Acid Terpenoids
    Ilaria Sogno, Nicola Vannini, Girieca Lorusso, Rosaria Cammarota, Douglas McClain Noonan, Luca Generoso, Michael B. Sporn, Adriana Albini · 2008 · Recent results in cancer research/Recent Results in Cancer Research
  16. Enhanced antitumor effect of novel dual-targeted paclitaxel liposomes
    Shuyan Meng, Bo Su, Wěi Li, Yongmei Ding, Liang Tang, Wei Zhou, Yin Song, Heyan Li, Caicun Zhou · 2010 · Nanotechnology
  17. A Novel Combretastatin A‐4 Derivative, AC‐7700, Shows Marked Antitumor Activity against Advanced Solid Tumors and Orthotopically Transplanted Tumors
    Yukio Nihei, Yasuyo Suga, Yoshihiro Morinaga, Kazuo Ohishi, Akira Okano, Koji Ohsumi, Toshihiro Hatanaka, Ryusuke Nakagawa, Takashi Tsuji, Yukio Akiyama et al. · 1999 · Japanese Journal of Cancer Research
  18. Cells encapsulated in alginate: a potential system for delivery of recombinant proteins to malignant brain tumours
    Tracy‐Ann Read, Vidar Stensvaag, Harald Vindenes, Elling Ulvestad, Rolf Bjerkvig, Frits Alan Thorsen · 1999 · International Journal of Developmental Neuroscience
  19. Phase I/II Trial of the Safety and Efficacy of AE-941 (Neovastat®) in the Treatment of Non–Small-Cell Lung Cancer
    Jean Latreille, Gerald Batist, Francis Laberge, Pierre Champagne, Daniel Croteau, Pierre Falardeau, Carey M. Levinton, Claude Hariton, William Kenneth Evans, Éric Dupont · 2003 · Clinical Lung Cancer
  20. Pathophysiology of tumor neovascularization
    Mitsuko Furuya, Mariko Nishiyama, Yoshitoshi Kasuya, Sadao Kimura, Hiroshi Ishikura · 2005 · Vascular Health and Risk Management
  21. Increased angiogenesis in bone marrow of children with acute lymphoblastic leukaemia has no prognostic significance
    Martin A. Pulè, Christian Gulmann, Deirdre Dennis, Corrina McMahon, Michael D. Jeffers, Owen Patrick Smith · 2002 · British Journal of Haematology
  22. Novel Targets for Lung Cancer Therapy: Part II
    Grace Kho Dy, Alex A. Adjei · 2002 · Journal of Clinical Oncology
  23. In Vivo Microscopy of Targeted Vessel Occlusion Employing Acoustic Droplet Vaporization
    Stanley Samuel, Ambroise Duprey, Mario L. Fabiilli, Joseph L. Bull, J. Brian Fowlkes · 2012 · Microcirculation
  24. Elevated serum endostatin is associated with poor outcome in patients with non‐Hodgkin lymphoma
    Petri Bono, Lasse M. Teerenhovi, Heikki Joensuu · 2003 · Cancer
  25. Targeted therapies of cancer: Angiogenesis inhibition seems not enough
    Ilse Roodink, William P. J. Leenders · 2010 · Cancer Letters
  26. Recombinant endostatin forms amyloid fibrils that bind and are cytotoxic to murine neuroblastoma cells in vitro
    Onno Kranenburg, Loes M. J. Kroon-Batenburg, Arie Reijerkerk, Yaping Wu, Emile E. Voest, Martijn F.B.G. Gebbink · 2003 · FEBS Letters
  27. The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer
    Giles Cox, William P. Steward, Kenneth John O'Byrne · 1999 · Thorax
  28. The antiangiogenic agent Neovastat (AE-941) induces endothelial cell apoptosis.
    Dominique Boivin, Sébastien P. Gendron, Édith Beaulieu, Denis Gingras, Richard Béliveau · 2002 · PubMed
  29. Hepatocytes as a source of collagen type XVIII endostatin
    Detlef Schuppan, Thorsten Cramer, Michael W Bauer, Thomas Strefeld, Eckhart G. Hahn, Hermann Herbst · 1998 · The Lancet
  30. Significance of angiogenesis in cancer therapy
    Deborah A. McNamara, Judith H. Harmey, T. N. Walsh, Henry Paul Redmond, D. J. Bouchier‐Hayes · 1998 · British journal of surgery
  31. Unfulfilled Promise of Endostatin in a Gene Therapy-Xenotransplant Model of Human Acute Lymphocytic Leukemia
    Wolfgang Eisterer, Xiaoyan Jiang, Thomas Bachelot, Robert Pawliuk, Carolina Abramovich, Philippe Leboulch, Donna E. Hogge, Connie J. Eaves · 2002 · Molecular Therapy
  32. A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumours
    W-C. Yen, Rene Y. Prudente, Manny Corpuz, Andres F. Negro-Vilar, William W. Lamph · 2006 · British Journal of Cancer
  33. Mechanism of inhibition of ascites tumor growth in mice by curcumin is mediated by NF-kB and caspase activated DNase
    Madesh Belakavadi, Bharathi P. Salimath · 2005 · Molecular and Cellular Biochemistry
  34. Systemic Combination Virotherapy for Melanoma with Tumor Antigen-Expressing Vesicular Stomatitis Virus and Adoptive T-cell Transfer
    Diana M. Rommelfanger, Phonphimon Wongthida, Rosa María Díaz, Karen M. Kaluza, Jill Thompson, Timothy J. Kottke, Richard G. Vile · 2012 · Cancer Research
  35. Estradiol and Tamoxifen Regulate Endostatin Generation via Matrix Metalloproteinase Activity in Breast CancerIn vivo
    Ulrika W. Nilsson, Charlotta Dabrosin · 2006 · Cancer Research
  36. Science, medicine, and the future: Antivascular therapy: a new approach to cancer treatment
    Andrew J. Hayes, L Y Li, M. E. Lippman · 1999 · BMJ
  37. Mcl-1 Is a Novel Therapeutic Target for Human Sarcoma
    Christiane Thallinger, Markus F. Wolschek, Helmut Maierhofer, Hans Skvara, Hubert Pehamberger, Brett P. Monia, Burkhard Jansen, Volker Wacheck, Edgar Selzer · 2004 · Clinical Cancer Research
  38. Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. current status and future perspective
    Keren Paz · 2005 · Frontiers in bioscience
  39. Endostatin Binds to Blood Vessels in Situ. Independent of Heparan Sulfate and Does Not Compete for Fibroblast Growth Factor-2 Binding
    Zhen Chang, Aung Choon, Andreas Friedl · 1999 · American Journal Of Pathology
  40. Treatment of melanoma cells with a bcl-2/bcl-xL antisense oligonucleotide induces antiangiogenic activity
    Donatella Del Bufalo, Daniela Trisciuoglio, Marco Scarsella, Uwe Zangemeister‐Wittke, Gabriella Zupi · 2003 · Oncogene
  41. Tumour progression and angiogenesis in bone metastasis from breast cancer: new approaches to an old problem
    Gabri van der Pluijm, Clemens W.G.M. Löwik, Socrates E. Papapoulos · 2000 · Cancer Treatment Reviews
  42. Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinoma in a transgenic mouse model.
    Yumi Yokoyama, Jeffrey E. Green, Vikas P. Sukhatme, Sundaram Ramakrishnan · 2000 · PubMed
  43. Anti-angiogenesis Therapy and Strategies for Integrating It with Adjuvant Therapy
    Adrian Llewellyn Harris · 1998 · Recent results in cancer research/Recent Results in Cancer Research
  44. Intracellular Ca2+ signaling in endothelial cells by the angiogenesis inhibitors endostatin and angiostatin
    Lianwei Jiang, Vivekanand Jha, Mohanraj Dhanabal, Vikas P. Sukhatme, Seth L. Alper · 2001 · American Journal of Physiology-Cell Physiology
  45. Halofuginone Inhibits Angiogenesis and Growth in Implanted Metastatic Rat Brain Tumor Model-an MRI Study
    Rinat Abramovitch, Anna Itzik, Hila Harel, Amon Nagler, Israël Vlodavsky, Tali Siegal · 2004 · Neoplasia
  46. Structure elucidation {spectroscopic, single crystal X-ray diffraction and computational DFT studies} of new tailored benzenesulfonamide derived Schiff base copper(II) intercalating complexes: Comprehensive biological profile {DNA binding, pBR322 DNA cleavage, Topo I inhibition and cytotoxic activity}
    Zeenat Afsan, Thierry Roisnel, Sartaj Tabassum, Farukh Arjmand · 2019 · Bioorganic Chemistry
  47. Endostatin Signaling and Regulation of Endothelial Cell–Matrix Interactions
    Sara A. Wickström, Kari K. Alitalo, Jorma Keski‐Oja · 2005 · Advances in cancer research
  48. Targeted radionuclide therapy for solid tumors: An overview
    Sally J. DeNardo, Gerald L. DeNardo · 2006 · International Journal of Radiation Oncology*Biology*Physics
  49. No grip, no growth: the conceptual basis of excessive proteolysis in the treatment of cancer
    Arie Reijerkerk, Emile E. Voest, Martijn F.B.G. Gebbink · 2000 · European Journal of Cancer
  50. The roles of proteolytic enzymes in the development of tumour-induced bone disease in breast and prostate cancer
    Julia K. L. Woodward, Ingunn Holen, Robert Edward Coleman, David J. Buttle · 2007 · Bone
  51. Carp Oil or Oleic Acid, but Not Linoleic Acid or Linolenic Acid, Inhibits Tumor Growth and Metastasis in Lewis Lung Carcinoma–Bearing Mice
    Yoshiyuki Kimura · 2002 · Journal of Nutrition
  52. Effect of Human Skin-Derived Stem Cells on Vessel Architecture, Tumor Growth, and Tumor Invasion in Brain Tumor Animal Models
    Federica Pisati, M. Belicchi, Francesco Acerbi, Chiara Marchesi, Carlo Giorgio Giussani, Manuela Gavina, Sophie Javerzat, Martin Hagedorn, Giorgio Giovanni Carrabba, Valeria Lucini et al. · 2007 · Cancer Research
  53. Antiangiogenic activity of endostatin inhibits c6 glioma growth
    Irene Peroulis, Nadeen Jonas, Mary Saleh · 2001 · International Journal of Cancer
  54. Gangliosides influence angiogenesis in an experimental mouse brain tumor.
    Mark G Manfredi, S Lim, Kevin P. Claffey, Thomas N. Seyfried · 1999 · PubMed
  55. Comparative study of isoflavone, quinoxaline and oxindole families of anti-angiogenic agents
    Jacqueline L. Whatmore, Elizabeth Swann, Paola Barraja, Jeffery J. Newsome, Melisa Bunderson, Howard D. Beall, John E. Tooke, Christopher J. Moody · 2002 · Angiogenesis
  56. Dermatological aspects of angiogenesis
    Paula Velasco, Bernhard Lange‐Asschenfeldt · 2002 · British Journal of Dermatology
  57. Bubble splitting in bifurcating tubes: a model study of cardiovascular gas emboli transport
    Andrés J. Calderón, J. Brian Fowlkes, Joseph L. Bull · 2005 · Journal of Applied Physiology
  58. Imaging vascular physiology to monitor cancer treatment
    George Robert Laking, Catharine West, David L. Buckley, Julian C. Matthews, Pat Price · 2006 · Critical Reviews in Oncology/Hematology
  59. Platelet‐activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration
    Thomas W. Axelrad, Dayanand D. Deo, Paulo Ottino, Jennefer Van Kirk, Nicolas Guillermo Bazan, Haydee E. P. Bazán, Jay D. Hunt · 2004 · The FASEB Journal
  60. Analysis of a “phase transition” from tumor growth to latency
    P. P. Delsanto, Afra Romano, Marco Scalerandi, Gianpiero Pescarmona · 2000 · Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics
  61. Development of lentiviral vectors for antiangiogenic gene delivery
    Toshiaki Shichinohe, Bernard H. Bochner, Kazuo Mizutani, Miyako Nishida, Susan Gilliam-Hegarich, Luigi Naldini, Noriyuki Kasahara · 2001 · Cancer Gene Therapy
  62. Endostatin cDNA/Cationic liposome complexes as a promising therapy to prevent lung metastases in osteosarcoma: study in a human-like rat orthotopic tumor
    Aurélie Dutour, Jacques Monteil, François Paraf, Jean Louis Charissoux, Cortina Kaletta, Birgitta Sauer, Kurt Naujoks, Michel Rigaud · 2004 · Molecular Therapy
  63. Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts
    Jian Wang, Jiansheng Li, Zhi-Ming Zhai, Qiong Xue, Weidong Jia, Ge‐Liang Xu, Rong-Nan Xu, Hui‐Chuan Sun, Lu Wang, Ji-Hai Yu · 2003 · Journal of Cancer Research and Clinical Oncology
  64. Continuous Intravascular Secretion of Endostatin in Mice from Transduced Hematopoietic Stem Cells
    Robert Pawliuk, Thomas Bachelot, Omar Zurkiya, Anna Eriksson, Yihai Cao, Philippe Leboulch · 2002 · Molecular Therapy
  65. Inhibition of tumor specific angiogenesis by amentoflavone
    C. Guruvayoorappan, Girija Kuttan · 2008 · Biochemistry (Moscow)
  66. In vivo and in vitro characterisation of a protoporphyrin IX-cyclic RGD peptide conjugate for use in photodynamic therapy
    Clare L. Conway, Ian O. Walker, Andrea Bell, David J. Roberts, Stanley B. Brown, David I. Vernon · 2007 · Photochemical & Photobiological Sciences
  67. The role of angiogenesis in prostate and other urologic cancers: a review.
    Jonathan I. Izawa, Colin P. Dinney · 2001 · Europe PMC (PubMed Central)
  68. Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patients
    Charlotte F.J.M. Peeters, Johan R. Westphal, Robert M.W. de Waal, Dirk J. Ruiter, Theo Wobbes, Theo J. M. Ruers · 2004 · International Journal of Cancer
  69. Aberrant Neuronal and Paracellular Deposition of Endostatin in Brains of Patients with Alzheimer's Disease
    Martin Hermann Deininger, Birte A. Fimmen, Dietmar Rudolf Thal, Hermann J. Schluesener, Richard Meyermann · 2002 · Journal of Neuroscience
  70. Restoration of functional defects in peripheral blood mononuclear cells isolated from cancer patients by thiol antioxidants alpha-lipoic acid and N-acetyl cysteine
    Giovanni Mantovani, Antonio Macci�, G. B. Melis, Loredana Mura, Elena Massa, Maria Caterina Mudu · 2000 · International Journal of Cancer
  71. Role of angiogenesis in chronic lymphocytic leukemia
    Tomislav Letilović, Radovan Vrḫovac, Srđan Verstovšek, Branimir S. Jaksic, Alessandra Ferrajoli · 2006 · Cancer
  72. Transcription-controlled gene therapy against tumor angiogenesis
    Shoshana Greenberger, Aviv Shaish, Nira Varda‐Bloom, Keren Levanon, Eyal Breitbart, Iris Goldberg, Iris Barshack, Israel Hodish, Niva Yacov, Livnat Bangio et al. · 2004 · Journal of Clinical Investigation
  73. Increased endostatin/collagen XVIII expression correlates with elevated VEGF level and poor prognosis in hepatocellular carcinoma
    Tsung‐Hui Hu, Chao‐Cheng Huang, Chia‐Ling Wu, Pey-Ru Lin, Shang‐Yun Liu, Jui‐Wei Lin, Jiin‐Haur Chuang, Ming Hong Tai · 2004 · Modern Pathology
  74. Modulation of Endothelial Cell Survival by an Inhibitor of Angiogenesis Thrombospondin-1: a Dynamic Balance
    Olga V. Volpert · 2000 · Cancer and Metastasis Reviews
  75. Frequent, moderate-dose cyclophosphamide administration improves the efficacy of cytochrome P-450/cytochrome P-450 reductase-based cancer gene therapy.
    Youssef Jounaïdi, David J. Waxman · 2001 · PubMed
  76. VEGFR-2 redirected CAR-T cells are functionally impaired by soluble VEGF-A competition for receptor binding
    Evripidis Lanitis, Paris Kosti, Catherine Ronet, Elisabetta Cribioli, Giorgia Rota, Aodrenn Spill, Patrick Reichenbach, Vincent Zoete, Denarda Dangaj Laniti, George Coukos et al. · 2021 · Journal for ImmunoTherapy of Cancer
  77. Oral delivery of a potent anti-angiogenic heparin conjugate by chemical conjugation and physical complexation using deoxycholic acid
    Farzana Alam, Taslim Ahmed Al-Hilal, Seung Woo Chung, Dong-Hyun Seo, Foyez Mahmud, Han Sung Kim, Sang Yoon Kim, Youngro Byun · 2014 · Biomaterials
  78. Future options of anti-angiogenic cancer therapy
    Yihai Cao · 2016 · 癌症：英文版
  79. Angiogenesis in malignant primary and metastatic brain tumors
    Jaap C. Reijneveld, Emile E. Voest, MARTIN J.B. TAPHOORN · 2000 · Journal of Neurology
  80. Pharmacokinetics of His-tag recombinant human endostatin in Rhesus monkeys1
    Haifeng Song, Xiu-wen LIU, Haining Zhang, Bao-Zhen Zhu, Shoujun Yuan, Shang-yi Liu, Tang Zhong-ming · 2005 · Acta Pharmacologica Sinica
  81. Antitumor Activities of TEM8-Fc: An Engineered Antibody-like Molecule Targeting Tumor Endothelial Marker 8
    Haifeng Duan, X.-W. Hu, Ji‐Long Chen, Li Gao, Y.-Y. Xi, You Lü, Junfa Li, Shourong Zhao, Jinjin Xu, H.-P. Chen et al. · 2007 · JNCI Journal of the National Cancer Institute
  82. Endothelial cell effects of cytotoxics: balance between desired and unwanted effects
    Filip De Vos, Pax H.B. Willemse, Elisabeth G.E. de Vries, Jourik A. Gietema · 2004 · Cancer Treatment Reviews
  83. Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy.
    Mengfeng Li, Caisheng Ye, Chong Feng, Frank Riedel, Xiaoning Liu, Qing Zeng, Jennifer Rubin Grandis · 2002 · PubMed
  84. Endostatin action and intracellular signaling: β-catenin as a potential target?
    Johan Dixelius, Michael J Cross, Tarô Matsumoto, Lena Claesson · 2003 · Cancer Letters
  85. The potential role of antivascular therapy in the adjuvant and neoadjuvant treatment of cancer
    Maartje Los, Emile E. Voest · 2001 · Seminars in Oncology
  86. Antiangiogenic agents
    Wayne D. Klohs, James M. Hamby · 1999 · Current Opinion in Biotechnology
  87. Early response to chemoradiotherapy for nasopharyngeal carcinoma treatment: Value of dynamic contrast‐enhanced 3.0 T MRI
    Dechun Zheng, Yunbin Chen, Xiangyi Liu, Ying Chen, Luying Xu, Ren Wang, Weibo Chen, Queenie Chan · 2014 · Journal of Magnetic Resonance Imaging
  88. A pH-sensitive polymeric nanovesicle based on biodegradable poly(ethylene glycol)-b-poly(2-(diisopropylamino)ethyl aspartate) as a MRI-visible drug delivery system
    Qiquan Sun, Du Cheng, Xingsu Yu, Zhaoshan Zhang, Jian Dai, Hao Li, Bi‐Ling Liang, Xintao Shuai · 2011 · Journal of Materials Chemistry
  89. Anti‐tumor activity of an anti‐endoglin monoclonal antibody is enhanced in immunocompetent mice
    Masanori Tsujie, Tomoko Tsujie, Hirofumi Toi, Shima Uneda, Ken SHIOZAKI, Hilda Tsai, Ben K. Seon · 2008 · International Journal of Cancer
  90. Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth
    Boqiang Hu, L Kou, Chao Li, L-P Zhu, Y-R Fan, Z-W Wu, J-J Wang, G-X Xu · 2009 · Cancer Gene Therapy
  91. Intra-arterial delivery of endostatin gene to brain tumors prolongs survival and alters tumor vessel ultrastructure
    Faith H. Barnett, Manuela Scharer-Schuksz, M Wood, Xue Li Yu, Thomas E. Wagner, Martin Friedlander · 2004 · Gene Therapy
  92. Non-viral endostatin plasmid transfection of mesenchymal stem cells via collagen scaffolds
    Xiaodan Sun, Lily Jeng, Catherine Bolliet, Bjorn Reino Olsen, Myron Spector · 2008 · Biomaterials
  93. Mathematical models of cancer dormancy
    Karen M. Page, Jonathan W. Uhr · 2004 · Leukemia & lymphoma/Leukemia and lymphoma
  94. Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices
    Laura Sanz, Peter Kjær Kristensen, Belén Blanco, Suzanne Facteau, Stephen J. Russell, Greg P. Winter, Luis Álvarez‐Vallina · 2002 · Gene Therapy
  95. Large-scale comparison of protein sequence alignment algorithms with structure alignments
    J.M. Sauder, Jonathan W. Arthur, Roland L. Dunbrack · 2000 · Proteins Structure Function and Bioinformatics
  96. Endostatin reduces vascularization, blood flow, and growth in a rat gliosarcoma
    Dag Reidar Sørensen, Tracy‐Ann Read, T. Porwol, Bjorn Reino Olsen, Rupert Timpl, Takako Sasaki, Per Ole Iversen, Haakon B. Benestad, B. Kim Lee Sim, Rolf Bjerkvig · 2002 · Neuro-Oncology
  97. Anti-Angiogenic Activity of Contortrostatin, a Disintegrin from Agkistrodon Contortrix Contortrix Snake Venom
    Vladislav S. Golubkov, Debra Hawes, Francis S. Markland · 2003 · Angiogenesis
  98. Angiogenesis inhibitors under study for the treatment of lung cancer
    Frances A. Shepherd, Srikala S. Sridhar · 2003 · Lung Cancer
  99. Approaches to preclinical screening of antiangiogenic agents
    Erwin A. Kruger, Paul H. Duray, Douglas K. Price, James M. Pluda, William D. Figg · 2001 · Seminars in Oncology
  100. Adeno-associated virus–mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo
    Wenyin Shi, Christian Teschendorf, Nicholas Muzyczka, Dietmar W. Siemann · 2002 · Cancer Gene Therapy